Answers are grounded in this paper and cite their sources.
Biochemical analysis demonstrates isolation of heat-labile accelerator globulin from human plasma, indicating its role in correcting prolonged prothrombin time.
There appears to be general agreement among investigators of blood clotting regarding the ex- istence in plasma of a heat-labile factor which po- tentiates the action of thromboplastin as a pro- thrombin converting agent (1). This clotting agent appears to be a protein which is not adsorbed on barium sulfate and which will correct the pro- longed prothrombin time of aged, oxalated, human plasma. There is a lack of agreement about its nomenclature; the terms accelerator globulin (2), proaccelerin (3), Factor V (4), and labile factor (5) being used predominately.
No takes yet. Share an insight, caveat, or question.
Cox et al. (1956) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: